Utility of positron emission tomography for determination of axillary metastasis of breast cancer

被引:0
|
作者
Posteki, Gokhan [1 ]
Guresin, Alican [1 ]
Guler, Sertac Ata [1 ]
Simsek, Turgay [1 ]
Canturk, Nuh Zafer [1 ]
机构
[1] Kocaeli Univ, Fac Med, Dept Gen Surg, Kocaeli, Turkiye
关键词
Axillary metastasis; breast cancer; positron emission tomography; F-18-FDG-PET/CT; ENHANCEMENT; PARAMETERS;
D O I
10.47717/turkjsurg.2023.5600
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The involvement of axillary lymph nodes plays a key role in breast cancer staging. Positron emission tomography is a promising modality for detecting axillary lymph node metastasis. In addition, nomograms are used to predict the status of axillary lymph nodes. In this study, the role of positron emission tomography in determining axillary metastasis and its correlation with the nomogram was evaluated. Material and Methods: The axillary maximum standard uptake value (SUVmax) values of the patients in the preoperative period, the features in the perioperative and postoperative specimen and Memorial Sloan Kettering Cancer Center nomogram data were evaluated. Results: As axillary SUVmax detected by Positron emission tomography in the preoperative period increased, so did the likelihood of lymph node involvement. Axillary SUVmax value were compared with Memorial Sloan Kettering Cancer Center nomogram data but no correlation was found. Age, lymph node number, histopathology results, mass diameter, presence or absence of lymphovascular invasion and/or perineural invasion, tumor type, estrogen receptor status, Ki67 and Cerb-B2 statuses were not correlated. However, axillary SUVmax was inversely correlated with grade and progester-one receptor status. Conclusion: Results from positron emission tomography of axillary lymph nodes in breasts cancer patients showed that SUVmax was only inversely related to cancer grade and progesterone receptor status while not correlating with other accepted parameters for tumor assessment. Thus there is insufficient reliability for the use of axillary SUVmax alone for accurate assessment of tumor characteristics at present.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 50 条
  • [31] The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
    Flamen, P
    Lerut, A
    van Custem, E
    Cambier, JP
    Maes, A
    De Wever, W
    Peeters, M
    De Leyn, P
    Van Raemdonck, D
    Mortelmans, L
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 120 (06): : 1085 - 1092
  • [32] The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer
    Duncan, James Robert
    Carr, David
    Kaffenberger, Benjamin Harris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) : 186 - 196
  • [33] Breast metastasis by medullary thyroid carcinoma detected by FDG positron emission tomography
    Nofech-Mozes, Sharon
    Mackenzie, Robert
    Kahn, Harriette J.
    Ehrlich, Lisa
    Raphael, Simon J.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2008, 12 (01) : 67 - 71
  • [34] Factors affecting the negative predictive value of positron emission tomography/computed tomography for axillary lymph node staging in breast cancer patients
    Kim, Jungbin
    Cho, Hyunjin
    Gwak, Geumhee
    Yang, Keunho
    Kim, Ji-Young
    Shin, Young-Joo
    Seo, Ye Young
    Park, Inseok
    ASIAN JOURNAL OF SURGERY, 2020, 43 (01) : 193 - 200
  • [35] Clinical applications of positron emission tomography in breast cancer patients
    Romer, W
    Avril, N
    Schwaiger, M
    ACTA MEDICA AUSTRIACA, 1997, 24 (02) : 60 - 62
  • [36] Positron emission tomography imaging in breast cancer: a pictorial essay
    Lim, C. Y.
    Tan, E. H.
    Tan, J. W.
    EJC SUPPLEMENTS, 2010, 8 (03): : 239 - 239
  • [37] Evolving role of positron emission tomography in breast cancer imaging
    Eubank, WB
    Mankoff, DA
    SEMINARS IN NUCLEAR MEDICINE, 2005, 35 (02) : 84 - 99
  • [38] Cost-effectiveness of positron emission tomography in breast cancer
    Sloka, JS
    Hollett, PD
    Mathews, M
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (05) : 351 - 360
  • [39] Value of fluorodeoxyglucose positron emission tomography in women with breast cancer
    Landheer, MLEA
    Steffens, MG
    Klinkenbijl, JHG
    Westenberg, AH
    Oyen, WJG
    BRITISH JOURNAL OF SURGERY, 2005, 92 (11) : 1363 - 1367
  • [40] Diagnostic value of positron emission tomography for detecting breast cancer
    Noh, DY
    Yun, IJ
    Kim, JS
    Kang, HS
    Lee, DS
    Chung, JK
    Lee, MC
    Youn, YK
    Oh, SK
    Choe, KJ
    WORLD JOURNAL OF SURGERY, 1998, 22 (03) : 223 - 228